Trans Cutaneous Electrical Acupoint Stimulation Versus TENS On Blood Pressure In Primary Hypertension Patients

NCT ID: NCT06401278

Last Updated: 2024-05-07

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-05-05
• Study Completion Date: 2024-08-10

Brief Summary

To compare between the effects of transcutaneous electrical acupoint stimulation and TENS on blood pressure and quality of life in patients with primary hypertension

BACKGROUND:

The current American College of Cardiology and the American Heart Association (ACC/AHA) 2017 guidelines define hypertension as systolic BP (SBP) of ≥130 mmHg or diastolic BP (DBP) of ≥80 mmHg. In adults, an increase of 20 mmHg in SBP or 10 mmHg in DBP is associated with more than a two-fold increase in mortality owing to stroke and other cardiovascular diseases. Hypertension accounts for 13% of premature deaths worldwide and is the third leading cause of disability-adjusted life years (Shah et al., 2022).

Transcutaneous electrical nerve stimulation of the Neiguan (P6) point with acupressure is possibly affecting the blood pressure by protecting the myocardial tissues and influencing the nervous system through regulating the autonomic nervous system function and reduction in sympathetic activity. (Hassanein et al., 2021).

HYPOTHESES There will be no a significant difference between the effects of transcutaneous electrical acupoint stimulation and TENS on blood pressure and quality of life in patients with primary hypertension

RESEARCH QUESTION:

Is there a significant difference between the effects of transcutaneous electrical acupoint stimulation and TENS on blood pressure and quality of life in patients with primary hypertension?

Evaluating equipment, pre-post intervension outcomes:

1. BP by Digital Sphygmomanometer

2. quality of life by The SF-12 health status questionnaire

3. nitric oxide level in blood by nitric Oxide analysis.

4. sleep quality. by Pittsburgh Sleep Quality Index (PSQI)

5. exercise capacity and endurance by Thirty-Second Sit-To-Stand Test (30 STST)

Conditions

Hypertension; Quality of Life

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Transcutaneous electrical acupoint stimulation (Group A):

Transcutaneous electrical acupoint stimulation :It will be performed by using the TENS device on acupoint (TEAS) as the following:

The patients will be placed in a relaxed comfortable sitting position with their back well supported. for 40 min three times weekly for a total of 6 weeks.The adhesive electrodes of the TENS device will be placed on the selected acupoint bilaterally Nei-Guan (PC6), Taichong (LR3), and Sanyinjiao (SP6)

Group Type: EXPERIMENTAL

Transcutaneous electrical acupoint stimulation

Intervention Type: DEVICE

It will be performed by using the TENS device on acupoint (TEAS) as the following:

The patients will be placed in a relaxed comfortable sitting position with their back well supported. for 40 min three times weekly for a total of 6 weeks.The adhesive electrodes of the TENS device will be placed on the selected acupoint bilaterally Nei-Guan (PC6), Taichong (LR3), and Sanyinjiao (SP6)

Transcutaneous electrical nerve stimulation(Group b):

TENS will be applied in the cervicothoracic ganglion region located between the C7 and T4 vertebral processes for 40 min three times weekly for a total of 6 weeks.

Group Type: EXPERIMENTAL

Transcutaneous electrical nerve stimulation (group b):

Intervention Type: DEVICE

TENS will be applied in the cervicothoracic ganglion region located between the C7 and T4 vertebral processes for 40 min three times weekly for a total of 6 weeks.

Control

Routine medical treatment: (Group c): receive only routine medical treatment (antihypertensive medication, instructions and education to control blood pressure)

• Nutrition Eat a diet that is high in fiber and potassium, and low in salt (sodium), added sugar, and fat.
• Lifestyle Do not use any products that contain nicotine or tobacco, such as cigarettes, and chewing tobacco.
• Identify your sources of stress and find ways to manage stress. This may include deep breathing or making time for fun activities.
• Do not drink alcohol

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Transcutaneous electrical acupoint stimulation

It will be performed by using the TENS device on acupoint (TEAS) as the following:

The patients will be placed in a relaxed comfortable sitting position with their back well supported. for 40 min three times weekly for a total of 6 weeks.The adhesive electrodes of the TENS device will be placed on the selected acupoint bilaterally Nei-Guan (PC6), Taichong (LR3), and Sanyinjiao (SP6)

Intervention Type: DEVICE

Transcutaneous electrical nerve stimulation (group b):

TENS will be applied in the cervicothoracic ganglion region located between the C7 and T4 vertebral processes for 40 min three times weekly for a total of 6 weeks.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• 1) Sixty patients from both sexes diagnosed with essential HT at least 6 months ago.

2) Their age will be ranged from 50 to 60 years old. 3) Their blood pressure will be ranged from (SBP is 140 -159 mmHg and/or DBP is 90-99 mmHg).

4) Their body mass index (BMI) ranged from will be ranged from 24.9 to 29.9 kg/m2.

5) All patients are medically stable and receive the same medical treatment 6) All patient nonsmoker or quitted smoking for at least 4-5 years 7) All patients will be similar in terms of status of functional activity, status of eating a salt-free diet and the presence of any chronic disease except HT

Exclusion Criteria

• 1) Secondary hypertension 2) Patients with cardiac problems e.g. atrial fibrillation, left bundle-branch block, heart failure, recent myocardial infarction, coronary artery disease, or participation in cardiac rehabilitation following bypass surgery.

3) Patients with history, symptoms of, and/or laboratory reports suggestive of renal, neurologic, or hepatic complications.

4) Use of a cardiac pacemaker 5) Any metal implants at site of application of TENS 6) Dermatological abnormalities at the site of the application of TENS 7) Obesity with body mass index (BMI) > 30 kg/m2 8) Smoker, diabetes. 9) Soft tissue, nerve, and vascular diseases of upper or lower extremities which hinder the application of TEAS.

• Minimum Eligible Age: 50 Years
• Maximum Eligible Age: 60 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Tawfik Tawfik Mahmoud Emara

OTHER

Sponsor Role: lead

Responsible Party

Tawfik Tawfik Mahmoud Emara

Assistant Lecturer

Responsibility Role: SPONSOR_INVESTIGATOR

Locations

Faculty of physical therapy- Cairo Uni.

Giza, , Egypt

Site Status: RECRUITING

Countries

Egypt

Facility Contacts

Hanan Mohamed, BSc

Role: primary

eth.com@pt.cu.edu.eg

01151312322 ext. 002

Other Identifiers

P.T.REC/012/004443

Identifier Type: -

Identifier Source: org_study_id